Search Orphan Drug Designations and Approvals
-
Generic Name: | 4-Chloro-N-[5-methyl-2-(7H-pyrrolo[2,3-d]pyrimidin-4-ylcarbonyl)-3-pyridinyl]-3-(trifluoromethyl)benzenesulfonamide, sodium salt |
---|---|
Date Designated: | 09/12/2018 |
Orphan Designation: | Treatment of focal segmental glomerulosclerosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
ChemoCentryx, Inc. 850 Maude Avenue Mountain View, California 94043 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-